221 related articles for article (PubMed ID: 11182222)
21. Mechanisms of loss of HLA class I expression on colorectal tumor cells.
Browning M; Petronzelli F; Bicknell D; Krausa P; Rowan A; Tonks S; Murray N; Bodmer J; Bodmer W
Tissue Antigens; 1996 May; 47(5):364-71. PubMed ID: 8795136
[TBL] [Abstract][Full Text] [Related]
22. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
Cromme FV; Airey J; Heemels MT; Ploegh HL; Keating PJ; Stern PL; Meijer CJ; Walboomers JM
J Exp Med; 1994 Jan; 179(1):335-40. PubMed ID: 8270878
[TBL] [Abstract][Full Text] [Related]
23. Analysis of HLA-E expression in human tumors.
Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F
Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909
[TBL] [Abstract][Full Text] [Related]
24. Analysis of HLA class Ia transcripts in human leukaemias.
Majumder D; Bandyopadhyay D; Chandra S; Mukhopadhayay A; Mukherjee N; Bandyopadhyay SK; Banerjee S
Immunogenetics; 2005 Sep; 57(8):579-89. PubMed ID: 16133450
[TBL] [Abstract][Full Text] [Related]
25. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.
Vitale M; Rezzani R; Rodella L; Zauli G; Grigolato P; Cadei M; Hicklin DJ; Ferrone S
Cancer Res; 1998 Feb; 58(4):737-42. PubMed ID: 9485029
[TBL] [Abstract][Full Text] [Related]
26. Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism.
Shen L; Chiang AK; Liu WP; Li GD; Liang RH; Srivastava G
Int J Cancer; 2001 Jun; 92(5):692-6. PubMed ID: 11340574
[TBL] [Abstract][Full Text] [Related]
27. MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice.
Ljunggren HG; Van Kaer L; Sabatine MS; Auchincloss H; Tonegawa S; Ploegh HL
Int Immunol; 1995 Jun; 7(6):975-84. PubMed ID: 7577806
[TBL] [Abstract][Full Text] [Related]
28. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
[TBL] [Abstract][Full Text] [Related]
29. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
30. Analysis of HLA-G expression in breast cancer tissues.
Palmisano GL; Pistillo MP; Fardin P; Capanni P; Nicolò G; Salvi S; Spina B; Pasciucco G; Ferrara GB
Hum Immunol; 2002 Nov; 63(11):969-76. PubMed ID: 12392849
[TBL] [Abstract][Full Text] [Related]
31. Multiple mechanisms underlie HLA dysregulation in cervical cancer.
Brady CS; Bartholomew JS; Burt DJ; Duggan-Keen MF; Glenville S; Telford N; Little AM; Davidson JA; Jimenez P; Ruiz-Cabello F; Garrido F; Stern PL
Tissue Antigens; 2000 May; 55(5):401-11. PubMed ID: 10885560
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2).
Androlewicz MJ; Ortmann B; van Endert PM; Spies T; Cresswell P
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12716-20. PubMed ID: 7809108
[TBL] [Abstract][Full Text] [Related]
33. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
[TBL] [Abstract][Full Text] [Related]
34. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer.
Kaklamanis L; Leek R; Koukourakis M; Gatter KC; Harris AL
Cancer Res; 1995 Nov; 55(22):5191-4. PubMed ID: 7585572
[TBL] [Abstract][Full Text] [Related]
35. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
[TBL] [Abstract][Full Text] [Related]
36. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.
Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K
J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826
[TBL] [Abstract][Full Text] [Related]
37. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.
Kamarashev J; Ferrone S; Seifert B; Böni R; Nestle FO; Burg G; Dummer R
Int J Cancer; 2001 Jan; 95(1):23-8. PubMed ID: 11241306
[TBL] [Abstract][Full Text] [Related]
38. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.
de Miranda NF; Nielsen M; Pereira D; van Puijenbroek M; Vasen HF; Hes FJ; van Wezel T; Morreau H
J Pathol; 2009 Sep; 219(1):69-76. PubMed ID: 19462419
[TBL] [Abstract][Full Text] [Related]
39. Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.
Wintzer HO; Benzing M; von Kleist S
Br J Cancer; 1990 Aug; 62(2):289-95. PubMed ID: 2201398
[TBL] [Abstract][Full Text] [Related]
40. Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.
Maiorana A; Cesinaro AM; Fano RA; Collina G
Clin Exp Metastasis; 1995 Jan; 13(1):43-8. PubMed ID: 7820955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
